Menu
IPO market
IPO market
Bio Medica Laboratories IPO is a SME book building IPO. Issue size is 52 Cr. Price band is ₹132 to ₹139 per share. Minimum investment is ₹2.78 L. Lot size is 1000 shares. Open from 21 May 2026 to 25 May 2026. Allotment on 26 May 2026. Listing on 29 May 2026 at NSE. Managed by Narnolia Financial Services Ltd. Registrar: Skyline Financial Services Private Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Official documents: RHP.
Price band, lot, minimum application, and issue window at a glance.
Subscription, allotment, refund, share credit, and listing milestones.
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,78,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,17,000 |
| S-HNI (UPI) | 3 | 3,000 | ₹4,17,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,73,000 |
| B-HNI (Min) | 8 | 8,000 | ₹11,12,000 |
From the company / RHP narrative.
How the issuer plans to use IPO proceeds.
Figures from the IPO financial table (₹ Cr). Switch metric to compare years.
Bio Medica Laboratories IPO
Pre-filled: Issue Price = ₹139, Lot Size = 1,000 shares, Listing Price = ₹111.2
| Category | Lots | Investment | At listing | Loss |
|---|---|---|---|---|
| Retail (Min) | 2 | ₹2,78,000 | ₹111 | -₹55,600 |
| S-HNI (Min) | 3 | ₹4,17,000 | ₹111 | -₹83,400 |
| S-HNI (UPI) | 3 | ₹4,17,000 | ₹111 | -₹83,400 |
| S-HNI (Max) | 7 | ₹9,73,000 | ₹111 | -₹1,94,600 |
| B-HNI (Min) | 8 | ₹11,12,000 | ₹111 | -₹2,22,400 |
Profit based on the official listing price for each investor category.
A quick overview of key terms, dates, and how to track this IPO.
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Reserved portion of the issue by investor category (break data).
